Green Journals

Year	A+	A	B
2026		✓	✓
2025		✓	✓
2024		✓	✓
2023		✓	✓
2021/2022		✓	✓
2020		✓	✓
2019	✓	✓	✓
2018		✓

Targeting androgen receptor signaling to enhance cancer immunotherapy

David A. Bader, Binita Chakraborty, Donald P. McDonnell et al.

2026-11 Vol. 47 Issue 11 Pages 1252-1267

DOI: 10.1016/j.tips.2025.11.003

Precision toxicity control in checkpoint immunotherapy

Zhen Sun, Xiaoyi Yang, Weiming Shen et al.

2026-11 Vol. 47 Issue 11 Pages 1268-1282

DOI: 10.1016/j.tips.2026.09.005

Directions for achieving effective next-generation immunotherapies

Eyad Elkord, Yanhong Shi, Salvador Ventura et al.

2026-11 Vol. 47 Issue 11 Pages 1192-1197

DOI: 10.1016/j.tips.2026.10.004

Advisory Board and Contents

2026-11 Vol. 47 Issue 11 Pages i-ii

DOI: 10.1016/s0165-6147(26)00268-3

Dupilumab (DUPIXENT) for bullous pemphigoid

Gowtham Subramanian, Wei Jun Lam, Elizabeth Huiwen Tham et al.

2026-11 Vol. 47 Issue 11 Pages 1336-1337

DOI: 10.1016/j.tips.2026.05.003

Engineering monocytes and macrophages for therapeutic control

Yunzhu Chen, Christine E. Brown, Yanhong Shi et al.

2026-11 Vol. 47 Issue 11 Pages 1321-1335

DOI: 10.1016/j.tips.2026.09.009

Epigenetic programming via lysine-specific demethylase 1 regulates responses to immune checkpoint blockade

Xiaoshuang Niu, Bin Yu

2026-11 Vol. 47 Issue 11 Pages 1222-1234

DOI: 10.1016/j.tips.2026.09.006

Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities

Jiawen Xie, Hayam Hamdy, Eyad Elkord

2026-11 Vol. 47 Issue 11 Pages 1235-1251

DOI: 10.1016/j.tips.2026.03.007

STING-mediated cancer immunotherapy: emerging modalities and beyond

Ramesha Hanumanthappa, Nandakumar Dalavaikodihalli Nanjaiah, Sudhir H. Ranganath

2026-11 Vol. 47 Issue 11 Pages 1213-1221

DOI: 10.1016/j.tips.2026.07.002

November 2026 issue first authors

Abhinav Purohit, Jiawen Xie, Giulia Pesce et al.

2026-11 Vol. 47 Issue 11 Pages 1198-1209

DOI: 10.1016/j.tips.2026.10.005

Journal Report

Journal Information

Classification History

Recent Articles